Attached files

file filename
EX-99.2 - EXHIBIT 99.2 AMASYS CORPORATION WARRANT ISSUED TO CHIP BRIAN - StemGen, Inc.exhibit99_2.htm
EX-99.1 - EXHIBIT 99.1 NOTE BETWEEN AMASYS CORPORATION AND CHIP BRIAN, DATED AUGUST 31, 2011 - StemGen, Inc.exhibit99_1.htm
 
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  August 31, 2011

AMASYS Corporation
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware 0-21555  54-1812385
(State or Other Jurisdiction of Incorporation)
  (Commission File No.)    (I.R.S. Employer Identification No.)
 

6462 Little River Turnpike, Suite E, Alexandria, Virginia                                                                                              22312
    (Address of Principal Executive Offices)                                                                                                                                (Zip Code)


Registrant’s telephone number, including area code:  (703) 797-8111


Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
      CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
 


 
 
 
 

 

 
Item 1.01
Entry into a Material Definitive Agreement

On August 31, 2011, AMASYS Corporation (“AMASYS” or the “Company”) received an infusion of $10,000 in order to continue its operations in the near-term.  The Company executed a $10,000 note with Mr. Chip Brian, pursuant to which Mr. Brian advanced the Company $10,000 at a rate of 12% per annum.  Additionally, the Company granted 1,000,000 shares of restricted common stock and a warrant to purchase an additional 1,000,000 shares of restricted common stock at an exercise price of $0.01 per share as an inducement for Mr. Brian to make the loan.


Item 9.01.                      Financial Statements and Exhibits

(d)           Exhibits.

Exhibit No.                                Description

99.1  
Note between AMASYS Corporation and Chip Brian, dated August 31, 2011
 
99.2  
AMASYS Corporation Warrant issued to Chip Brian
 

 
 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

AMASYS CORPORATION



DATE:  September 6, 2011                                                   By:           /s/ C.W. Gilluly, Ed.D. 
C.W. Gilluly, Ed.D.
President, Chief Executive Officer, and Chief Financial Officer